These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17919087)

  • 1. PKC isozymes in chronic cardiac disease: possible therapeutic targets?
    Churchill E; Budas G; Vallentin A; Koyanagi T; Mochly-Rosen D
    Annu Rev Pharmacol Toxicol; 2008; 48():569-99. PubMed ID: 17919087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C (PKC) isozyme-specific substrates and their design.
    Kang JH; Toita R; Kim CW; Katayama Y
    Biotechnol Adv; 2012; 30(6):1662-72. PubMed ID: 22841933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.
    Jirousek MR; Gillig JR; Gonzalez CM; Heath WF; McDonald JH; Neel DA; Rito CJ; Singh U; Stramm LE; Melikian-Badalian A; Baevsky M; Ballas LM; Hall SE; Winneroski LL; Faul MM
    J Med Chem; 1996 Jul; 39(14):2664-71. PubMed ID: 8709095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization, anchoring, and functions of protein kinase C isozymes in the heart.
    Mackay K; Mochly-Rosen D
    J Mol Cell Cardiol; 2001 Jul; 33(7):1301-7. PubMed ID: 11437536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C isozymes as potential therapeutic targets in immune disorders.
    Lee MR; Duan W; Tan SL
    Expert Opin Ther Targets; 2008 May; 12(5):535-52. PubMed ID: 18410238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKD at the crossroads of DAG and PKC signaling.
    Wang QJ
    Trends Pharmacol Sci; 2006 Jun; 27(6):317-23. PubMed ID: 16678913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alpha(1)-adrenoceptor subtype- and protein kinase C isoform-dependence of Norepinephrine's actions in cardiomyocytes.
    Rohde S; Sabri A; Kamasamudran R; Steinberg SF
    J Mol Cell Cardiol; 2000 Jul; 32(7):1193-209. PubMed ID: 10860763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of protein kinase C signaling in cardiac myocytes.
    Malhotra A; Kang BP; Opawumi D; Belizaire W; Meggs LG
    Mol Cell Biochem; 2001 Sep; 225(1-):97-107. PubMed ID: 11716370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptor proteins in protein kinase C-mediated signal transduction.
    Schechtman D; Mochly-Rosen D
    Oncogene; 2001 Oct; 20(44):6339-47. PubMed ID: 11607837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential activation of PKC isozymes by 14-3-3 zeta protein.
    Acs P; Szallasi Z; Kazanietz MG; Blumberg PM
    Biochem Biophys Res Commun; 1995 Nov; 216(1):103-9. PubMed ID: 7488074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anchoring proteins for protein kinase C: a means for isozyme selectivity.
    Mochly-Rosen D; Gordon AS
    FASEB J; 1998 Jan; 12(1):35-42. PubMed ID: 9438408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergence and complexities in DAG signaling: looking beyond PKC.
    Yang C; Kazanietz MG
    Trends Pharmacol Sci; 2003 Nov; 24(11):602-8. PubMed ID: 14607084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological regulation of network kinetics by protein kinase C localization.
    Mochly-Rosen D; Kauvar LM
    Semin Immunol; 2000 Feb; 12(1):55-61. PubMed ID: 10723798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C in cardiac disease and as a potential therapeutic target.
    Murphy S; Frishman WH
    Cardiol Rev; 2005; 13(1):3-12. PubMed ID: 15596021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKC-interacting proteins: from function to pharmacology.
    Poole AW; Pula G; Hers I; Crosby D; Jones ML
    Trends Pharmacol Sci; 2004 Oct; 25(10):528-35. PubMed ID: 15380937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.
    Clark EA; Leach KL; Trojanowski JQ; Lee VM
    Lab Invest; 1991 Jan; 64(1):35-44. PubMed ID: 1990207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin action in skeletal muscle: isozyme-specific effects of protein kinase C.
    Idris I; Gray S; Donnelly R
    Ann N Y Acad Sci; 2002 Jun; 967():176-82. PubMed ID: 12079846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein scaffolds, lipid domains and substrate recognition in protein kinase C function: implications for rational drug design.
    Walker JW
    Handb Exp Pharmacol; 2008; (186):185-203. PubMed ID: 18491053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of protein kinase C isozymes in cardiac myocytes.
    Disatnik MH; Buraggi G; Mochly-Rosen D
    Exp Cell Res; 1994 Feb; 210(2):287-97. PubMed ID: 8299726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.
    Yu H; Cai JJ; Lee HC
    Mol Pharmacol; 1996 Sep; 50(3):549-55. PubMed ID: 8794893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.